BioSpace News Archive

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that management will participate in the following investor events.

Envoy Medical® Corporation announced the first patient has been enrolled and implanted in the Acclaim® Cochlear Implant early feasibility study at Mayo Clinic in Rochester, Minn.

Horizon Therapeutics plc announced it has been named to Seramount’s 2022 Inclusion Index.

Pieris Pharmaceuticals, Inc. announced that the first subject has been dosed in the phase 1 study of PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis and other forms of fibrotic lung disease.

Cumberland Pharmaceuticals Inc. announced that it has moved its headquarters to the Broadwest campus in the Vanderbilt/West End corridor of Nashville.

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II COVID-19 “universal” booster vaccine, AKS-452.

SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to announce the publication of “Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients” in Scientific Reports.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced Teyana Taylor as the latest Xeomin® (incobotulinumtoxinA) brand partner.

The Global Congestive Heart Failure Drugs Market Size accounted for USD 7.15 billion in 2022 and is estimated to achieve a market size of USD 20.43 Billion by 2030 growing at a CAGR of 15.9% from 2022 to 2030.

Carisma Therapeutics Inc. (Carisma Therapeutics) announced today the acceptance of multiple abstracts to be presented at the upcoming Society for Immunotherapy of Cancer (SITC) 37th Anniversary Annual Meeting in Boston, Massachusetts, which is being held November 8 to November 12, 2022.